Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 27 results.
User Information
Export Records
  1. 1.   Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease
  2. Audley, John; Gliniewicz, Emily F; Zarember, Kol A; Hong, Hanna S; Wald, Gal; Kuhns,Doug; Kang, Elizabeth; Malech, Harry L; Suffredini, Anthony F; Noveck, Robert J; Dinubile, Mark J; Levinson, Susan L; Stossel, Thomas P; Gallin, John I
  3. Inflammation. 2020, Sep 04;
  1. 2.   Detection of Beta-Glucan Contamination in Nanotechnology-Based Formulations
  2. Neun,Barry; Cedrone,Edward; Potter, Timothy M.; Crist,Rachael; Dobrovolskaia,Marina
  3. Molecules (Basel, Switzerland). 2020, AUG; 25(15):
  1. 3.   Detection of Endotoxin in Nano-formulations Using Limulus Amoebocyte Lysate (LAL) Assays
  2. Neun,Barry; Dobrovolskaia,Marina
  3. Journal of visualized experiments : JoVE. 2019, Jan 30; (143):
  1. 4.   High-Mobility Group Nucleosome-Binding Protein 1 as Endogenous Ligand Induces Innate Immune Tolerance in a TLR4-Sirtuin-1 Dependent Manner in Human Blood Peripheral Mononuclear Cells
  2. Arts, Rob J W; Huang, Po-Kai; Yang, De; Joosten, Leo A B; van der Meer, Jos W M; Oppenheim, Joost; Netea, Mihai G; Cheng, Shih-Chin
  3. Frontiers in Immunology. 2018, Mar 14; 9: 526.
  1. 5.   Industrial hog farming is associated with altered circulating immunological markers
  2. Hofmann, Jonathan N; Shiels, Meredith S; Friesen, Melissa C; Kemp, Troy; Chaturvedi, Anil K; Lynch, Charles F; Parks, Christine G; Pinto, Ligia; Hildesheim, Allan; Alavanja, Michael C R; Beane Freeman, Laura E
  3. Occupational and Environmental Medicine. 2018, Mar; 75(3): 212-217.
  1. 6.   Altered Expression of SHIP, a Toll-like Receptor Pathway Inhibitor, Is Associated With the Severity of Liver Fibrosis in Chronic Hepatitis C Virus Infection
  2. Katsounas, A.; Trippler, M.; Kottilil, S.; Lempicki, R. A.; Gerken, G.; Schlaak, J. F.
  3. Journal of Infectious Diseases. 2011, Oct; 204(8): 1181-1185.
  1. 7.   Hofmeister Series Salts Enhance Purification of Plasmid DNA by Non-Ionic Detergents
  2. Lezin, G.; Kuehn, M. R.; Brunelli, L.
  3. Biotechnology and Bioengineering. 2011, Aug; 108(8): 1872-1882.
  1. 8.   Ambiguities in applying traditional Limulus Amebocyte Lysate tests to quantify endotoxin in nanoparticle formulations
  2. Dobrovolskaia, M. A.; Neun, B. W.; Clogston, J. D.; Ding, H.; Ljubimova, J.; McNeil, S. E.
  3. Nanomedicine. 2010, Jun; 5(4): 555-562.
  1. 9.   Inflammatory processes triggered by TCR engagement or by local cytokine expression: differences in profiles of gene expression and infiltrating cell populations
  2. Takase, H.; Yu, C. R.; Ham, D. I.; Chan, C. C.; Chen, J.; Vistica, B. P.; Wawrousek, E. F.; Durum, S. K.; Egwuagu, C. E.; Gery, I.
  3. Journal of Leukocyte Biology. 2006, Sep; 80(3): 538-545.
  1. 10.   Borrelia burgdorferi lipoprotein-mediated TLR2 stimulation causes the down-regulation of TLR5 in human monocytes
  2. Cabral, E. S.; Gelderblom, H.; Hornung, R. L.; Munson, P. J.; Martin, R.; Marques, A. R.
  3. Journal of Infectious Diseases. 2006, Mar; 193(6): 849-859.
  1. 11.   Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: Partial characterization and separation from interleukin 1 (IL 1)
  2. Yoshimura, T.; Matsushima, K.; Oppenheim, J. J.; Leonard, E. J.
  3. Journal of Immunology. 2005, NOV 1; 175(9): 5569-5574.
  1. 12.   Limited protective role of V-PYRRO/NO against cholestasis produced by alpha-naphthylisothiocyanate in mice
  2. Liu, J.; He, Y. Y.; Chignell, C. F.; Clark, J.; Myers, P.; Saavedra, J. E.; Waalkes, M. P.
  3. Biochemical Pharmacology. 2005, JUL 1; 70(1): 144-151.
  1. 13.   Transcriptional regulator CTCF controls human interleukin 1 receptor-associated kinase 2 promoter
  2. Kuzmin, I.; Geil, L.; Gibson, L.; Cavinato, T.; Loukinov, D.; Lobanenkov, V.; Lerman, M. I.
  3. Journal of Molecular Biology. 2005, FEB 18; 346(2): 411-422.
  1. 14.   Endogenous leukemia inhibitory factor attenuates endotoxin response
  2. Weber, M. A.; Schnyder-Candrian, S.; Schnyder, B.; Quesniaux, V.; Poli, V.; Stewart, C. L.; Ryffel, B.
  3. Laboratory Investigation. 2005, FEB; 85(2): 276-284.
  1. 15.   Triptolide attenuates endotoxin- and staphylococcal exotoxin-induced T-cell proliferation and production of cytokines and chemokines
  2. Krakauer, T.; Chen, X.; Howard, O. M. Z.; Young, H. A.
  3. Immunopharmacology and Immunotoxicology. 2005 27(1): 53-66.
  1. 16.   Proteomic analysis of lipid microdomains from lipopolysaccharide-activated human endothelial cells
  2. Karsan, A.; Blonder, J.; Law, J.; Yaquian, E.; Lucas, D. A.; Conrads, T. P.; Veenstra, T.
  3. Journal of Proteome Research. 2005, MAR-APR; 4(2): 349-357.
  1. 17.   Preclinical manufacture of an anti-HER2 scFv-PEG-DSPE, liposome-inserting conjugate. 1. Gram-scale production and purification
  2. Nellis, D. F.; Ekstrom, D. L.; Kirpotin, D. B.; Zhu, J. W.; Andersson, R.; Broadt, T. L.; Ouellette, T. F.; Perkins, S. C.; Roach, J. M.; Drummond, D. C.; Hong, K. L.; Marks, J. D.; Park, J. W.; Giardina, S. L.
  3. Biotechnology Progress. 2005, JAN-FEB; 21(1): 205-220.
  1. 18.   Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections
  2. Medvedev, A. E.; Lentschat, A.; Kuhns, D. B.; Blanco, J. C. G.; Salkowski, C.; Zhang, S. L.; Arditi, M. H.; Gallin, J. I.; Vogel, S. N.
  3. Journal of Experimental Medicine. 2003 198(4): 521-531.
  1. 19.   Induction of in vitro reprogramming by toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: Effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components
  2. Dobrovolskaia, M. A.; Medvedev, A. E.; Thomas, K. E.; Cuesta, N.; Toshchakov, V.; Ren, T. B.; Cody, M. J.; Michalek, S. M.; Rice, N. R.; Vogel, S. N.
  3. Journal of Immunology. 2003 170(1): 508-519.
  1. 20.   Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells
  2. Cui, Y. H.; Le, Y. Y.; Gong, W. H.; Proost, P.; Van Damme, J.; Murphy, W. J.; Wang, J. M.
  3. Journal of Immunology. 2002 168(1): 434-442.
  1. 21.   Role of the autocrine chemokines MIP-1 alpha and MIP-1 beta in the metastatic behavior of murine T cell lymphoma
  2. Menten, P.; Saccani, A.; Dillen, C.; Wuyts, A.; Struyf, S.; Proost, P.; Mantovani, A.; Wang, J. M.; Van Damme, J.
  3. Journal of Leukocyte Biology. 2002 72(4): 780-789.
  1. 22.   Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease
  2. Cui, Y. H.; Le, Y. Y.; Yazawa, H.; Gong, W. H.; Wang, J. M.
  3. Journal of Leukocyte Biology. 2002 72(4): 628-635.
  1. 23.   New insights into the biology of the acute phase response
  2. Suffredini, A. F.; Fantuzzi, G.; Badolato, R.; Oppenheim, J. J.; O'Grady, N. P.
  3. Journal of Clinical Immunology. 1999 19(4): 203-214.
  1. 24.   Role of p52 (NF-kappa B2) in LPS tolerance in a human B cell line
  2. Wedel, A.; Frankenberger, M.; Sulski, G.; Petersmann, I.; Kuprash, D.; Nedospasov, S.; Ziegler-Heitbrock, H. W. L.
  3. Biological Chemistry. 1999 380(10): 1193-1199.
  1. 25.   The Fracture-Flip Technique Reveals New Structural Features of the Escherichia Coli Cell Wall
  2. Risco, C.; Dasilva, P. P.
  3. Journal of Microscopy. 1998 189(Part 3): 213-218.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel